E N D
1. Exercise and Multiple Sclerosis
3. Introduction
4. Epidemiology 350,000-400,000 people in US
1 in 750
1 in 40 if a parent has MS
High incidence in young adults (20-50)
2.5 times higher in women
74% have a life expectancy of at least 25 yrs after diagnosis
Of that 74%, 66% are still ambulatory at the 25 year mark.
5. Pathophysiology Autoimmune disease
Destruction of myelin, oliogodendrocytes, and axons
Inflammatory cells move into the brain
Activation of natural killer cells attack myelin
6. Regenerated myelin is thinner with wider Nodes of Ranvier; slower conduction
Myelin is lost and replaced with scare tissue called sclerosis
Sometimes the neuron is damaged or broken Pathophysiology
7. Pathophysiology Antigen stimulates an immune response
A disruption in the balance between pro-inflammatory T helper 1 cells and anti-inflammatory Th2 cytokines with a shift to Th1.
Attack on myelin and myelin generating cells (oliogodendrocytes)
8. Pathophysiology The cause of MS is unknown
Genetic, infectious, environmental and/or autoimmune factors
Most researchers believe the damage to the myelin results from an abnormal response by the body’s immune system
Possible triggers: viruses, trauma, and heavy metals (e.g. mercury, lead, or manganese)
9. Researchers Find New Link Between Epstein-Barr Virus and MS April 12, 2006
Investigators report that individuals who showed signs of significant exposure to the Epstein-Barr virus, which causes several disorders including infectious mononucleosis, were twice as likely to develop multiple sclerosis up to 20 years later. The study, funded in part by a pilot research grant from the National MS Society, adds to previous evidence linking the virus to the risk of developing MS, but does not prove that EBV actually causes MS. The study, by Drs. Gerald N. DeLorenze (Kaiser Permanente Division of Research), Alberto Ascherio (Harvard School of Public Health) and colleagues, was published online April 10 in the Archives of Neurology.
10. Pathophysiology Require greater neural drive to obtain a give force production
Muscle fatigue
CNS
Peripheral (deconditioning)
Decrease functional capacity and daily activity
Increase in risk for heart disease, diabetes, etc.
11. Disease Pattern* Relapsing-remitting
Primary progressive
Secondary progressive
Progressive relapsing
12. Physical symptoms
13. Physical symptoms Ataxia, muscular weakness, general fatigue, spasticity, sensory disturbances, hypersensitivity to both internal and external temperature increases
15. Physical symptoms Decrease speed, strength, endurance and cardiorespiratory fitness.
Exercise prescription goal is to minimize their disability
Wide variation in physical capacity necessitates testing strength, flexibility, and CV endurance.
16. Fatigue Fatigue unrelated to physical activity
65% affected; 40% report it as the most disabling factor of MS
General malaise, tiredness, lassitude, fatigue without exercise
Wide range of general (systemic) fatigue among MS patients
Cognitive fatigue in some
17. Fatigue Possible causes
CNS
Systemic
Immune
Heat
Pharmacological treatments
18. Muscle Weakness Decrease isometric, isotonic, and isokinetic strength
Slower tension development
Mechanisms
? MU firing
? MU recruitment
? Conduction time
Muscle atrophy
? Aerobic capacity
? Anaerobic metab.
Inactivity
19. Depression
20. Spastic Paresis Exaggerated reflexes, resistance to stretch (spastic), and muscle weakness (paresis)
Aggravated by increase in body temperature
21. Poor Balance/Fall Risk Risk of fractures is 2-3.4 times higher.
Muscle weakness,
Impaired visual, somatosensory and vestibular input.
Poor judgement from cognitive deficits
Awareness of risk further decreases physical activity
22. Respiratory Ventilatory muscle weakness particular expiratory muscles
Ineffective cough leading to increase in respiratory diseases
Ventilatory muscle specific training and general aerobic training
23. Elimination Dysfunction Bladder control problems
80% of MS patients
Less storage
Less emptying
Greater risk of urinary tract infections
Bowel dysfunction
60% of MS patients
Constipation
All can lead to exercise anxiety
24. Secondary Diseases Heart disease
Obesity
Diabetes
etc
25. Medical Treatment
26. Medical Management Disease Modifying Drugs
Decrease frequency and severity of relapses
Decrease brain lesion development
Comorbidity drugs
Depression, fatigue, bowel and bladder function, etc.
Secondary diseases (pulmonary and/or heart)
Rehabilitation for spastic paresis
27. Exercise Exercise effects on progression of MS unknown
Exercise does not increase MS
28. Exercise Petajan et al (1996)
Regular exercise
better bladder and bowel control
less fatigue and depression
more positive attitude
reduces risks for other diseases
29. Exercise
30. Training
31. Training Bone health
Inactivity
Corticosteroids
May weaken bone tissue but may also improve able to perform weight baring activities
Sarcopenia
32. Training
33. Training Systemic Fatigue
Underlying causes: depression, anemia, & medication
Options:
34. Fitness Testing
35. Fitness Testing Heart rate
Linear increase but blunted
Fatigue lowers maximum heart rate
Lower age-predicted HRmax
Blood pressure
Blunted response
May result in insufficient perfusion to brain and muscles
36. Fitness Testing
37. Exercise Prescription
38. Cardiovascular Training Peak HR, not maximum HR
Modes: cycle, water exercises (treadmill, etc. in high functioning MS patients)
Strength exercises may need to precede aerobic to develop adequate muscle endurance
39. Intermittent Exercise Prevent or delay fatigue
Minimize increase in body temperature
40. Aquatic Exercise Body temperature
Pre-cooling before exercise
Buoyancy
Pre-cooling
41. Strength Training Individualized
Gradual progression
Closed-kinetic chain
Consideration to ROM
Can use various types of resistance
Attention to balance
42. Strength Training 2-3 sessions per week
1-3 sets of 8-15 RM per major muscle group
Emphasize seated exercises
Increases of 2-5% after 15RM
Less heat problems than aerobic exercise
43. Flexibility - Goals Improve balance
Improve posture
Counteract spasticity
Increase joint mobility
Increase muscle length
44. Flexibility - Goals Avoid overstretching; strain on nerves
Repeated short periods of gentle stretching better than one single stretchign session.
45. Flexibility - Guidelines
46. Flexibility Target spastic muscles
Passive stretching for immobilized MS patients
Other options:
progressive muscle relaxation
yoga
meditation
massage
47. Special Considerations Balance
Body temperature
Bladder function
48. Conclusions